Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M105,301Revenue $M153,290Net Margin (%)3.4Altman Z-Score3.7
Enterprise Value $M130,225EPS $4.6Operating Margin %6.2Piotroski F-Score7
P/E(ttm)21.6Beneish M-Score-2.5Pre-tax Margin (%)5.6Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %11.5Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %13.7Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow18.1y-y EBITDA Growth Rate %14.5ROA % (ttm)6.4Higher Current Ratio y-yY
Dividend Yield %1.5PEG1.6ROE % (ttm)14.0Less Shares Outstanding y-yY
Payout Ratio %30.0Shares Outstanding M1,098ROIC % (ttm)10.7Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSRobert Olstein 2015-12-31 Add0.24%$91.56 - $105.29
($97.91)
$ 95.86-2%Add 42.22%64,000
CVSNWQ Managers 2015-12-31 Reduce-0.03%$91.56 - $105.29
($97.91)
$ 95.86-2%Reduce -2.91%760,638
CVSMario Gabelli 2015-12-31 Reduce-0.02%$91.56 - $105.29
($97.91)
$ 95.86-2%Reduce -3.03%1,178,788
CVSKen Fisher 2015-12-31 Reduce$91.56 - $105.29
($97.95)
$ 95.86-2%Reduce -0.40%122,308
CVSRichard Pzena 2015-12-31 Add$91.56 - $105.29
($97.91)
$ 95.86-2%Add 0.02%527,389
CVSJames Barrow 2015-12-31 Reduce$91.56 - $105.29
($97.91)
$ 95.86-2%Reduce -3.85%368,897
CVSVanguard Health Care Fund 2015-09-30 Reduce-0.17%$95.12 - $113.45
($105.29)
$ 95.86-9%Reduce -20.92%3,084,020
CVSRobert Olstein 2015-09-30 Reduce-0.13%$95.12 - $113.45
($105.29)
$ 95.86-9%Reduce -21.05%45,000
CVSJohn Rogers 2015-09-30 Sold Out -0.1%$95.12 - $113.45
($105.29)
$ 95.86-9%Sold Out0
CVSMario Gabelli 2015-09-30 Reduce-0.08%$95.12 - $113.45
($105.29)
$ 95.86-9%Reduce -10.62%1,215,593
CVSJoel Greenblatt 2015-09-30 Reduce-0.06%$95.12 - $113.45
($105.29)
$ 95.86-9%Reduce -77.20%20,797
CVSNWQ Managers 2015-09-30 Reduce-0.05%$95.12 - $113.45
($105.29)
$ 95.86-9%Reduce -4.44%783,473
CVSKen Fisher 2015-09-30 Reduce-0.01%$95.12 - $113.45
($105.29)
$ 95.86-9%Reduce -21.50%122,805
CVSJames Barrow 2015-09-30 Reduce$95.12 - $113.45
($105.29)
$ 95.86-9%Reduce -1.62%383,650
CVSNWQ Managers 2015-06-30 Reduce-0.46%$98.74 - $106.47
($102.19)
$ 95.86-6%Reduce -30.15%819,859
CVSJoel Greenblatt 2015-06-30 Reduce-0.14%$98.74 - $106.47
($102.19)
$ 95.86-6%Reduce -66.50%91,217
CVSMario Gabelli 2015-06-30 Reduce-0.04%$98.74 - $106.47
($102.19)
$ 95.86-6%Reduce -5.44%1,359,978
CVSTom Gayner 2015-06-30 Add0.01%$98.74 - $106.47
($102.19)
$ 95.86-6%Add 0.82%247,000
CVSJames Barrow 2015-06-30 Add0.01%$98.74 - $106.47
($102.19)
$ 95.86-6%Add 27.87%389,950
CVSJohn Rogers 2015-06-30 Reduce$98.74 - $106.47
($102.19)
$ 95.86-6%Reduce -1.43%82,895
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these investors:


News about CVS:

Articles On GuruFocus.com
Mario Gabelli Comments on CVS Health Corp Feb 05 2016 
Steven Romick Sells Microsoft, Walgreens, CVS Jan 20 2016 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
First Pacific Advisors Slashes Stake in CVS Health Dec 17 2015 
Health Care Stocks Play Prominent Roles in Steven Romick's Transactions Dec 15 2015 
John Rogers Sells Position in CVS Dec 12 2015 
Taking a Look at Barron’s 10 Favorite Stocks for 2016 Dec 07 2015 
How the Walgreens-Rite Aid Deal Stacks Up Against Paulson's Merger Arbitrage Checklist Nov 05 2015 
Walgreens Buys Rite Aid to Avoid Loose Market Nov 04 2015 
How Rite Aid Deal Will Change Walgreens Oct 30 2015 

More From Other Websites
Express Scripts sees slow 2016 sales for new cholesterol drugs Feb 12 2016
Here’s what CEOs said on this week’s earnings calls Feb 12 2016
Dorman: The state of tech investing and all things pharma... Feb 12 2016
CVS Earnings: Strong Performance Driven by Acquisitions and Growth In Specialty Business Feb 12 2016
Froedtert & the Medical College affiliation with CVS to coordinate patient care Feb 11 2016
CVS Health Corp. Earnings Analysis: 2015 By the Numbers Feb 11 2016
Target Two-Fer: Growth Stock, Solid Dividend Feb 11 2016
Cisco PT Raised; SolarCity Upgraded; Disney, CVS PTs Cut Feb 10 2016
US Stock Indices Fell: Why Did They Follow Oil Prices? Feb 10 2016
CVS Health Offering Meningitis Vaccines to Residents in Santa Clara County, CA Feb 10 2016
CVS Posts Healthy profit, Affirms 2016 Guidance (CVS) Feb 10 2016
CVS Health Company Accordant Earns NCQA Accreditation for Case Management Feb 10 2016
[$$] CVS Profit Grows on Higher Sales of Prescription Drugs Feb 10 2016
[$$] CVS Profit Grows, But Forecast Soft Feb 09 2016
Stocks End Little Changed After Choppy Trading Day Feb 09 2016
Edited Transcript of CVS earnings conference call or presentation 9-Feb-16 1:30pm GMT Feb 09 2016
U.S. stocks end flat after seesaw session amid oil slide Feb 09 2016
CVS Health fourth-quarter profit, revenue rise Feb 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK